These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene. Wu S, Liu X, Solorzano MM, Kwock R, Avramis VI. J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan 01; 8(1):1-9. PubMed ID: 8548339 [Abstract] [Full Text] [Related]
3. Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene. Gröschel B, Höver G, Doerr HW, Cinatl J. Nucleosides Nucleotides Nucleic Acids; 2001 Jan 01; 20(4-7):487-92. PubMed ID: 11563064 [Abstract] [Full Text] [Related]
10. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger. Meng Q, Su T, O'Neill JP, Walker VE. Environ Mol Mutagen; 2002 Jan 01; 39(4):282-95. PubMed ID: 12112380 [Abstract] [Full Text] [Related]
12. Analysis of mutations in the Tk gene of Tk(+/-) mice treated as neonates with 3'-azido-3'-deoxythymidine (AZT). Mittelstaedt RA, Von Tungeln LS, Shaddock JG, Dobrovolsky VN, Beland FA, Heflich RH. Mutat Res; 2004 Mar 22; 547(1-2):63-9. PubMed ID: 15013700 [Abstract] [Full Text] [Related]